Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone H3K4 monomethyltransferase activity

KMT2D SETD1B

3.35e-048702GO:0140945
GeneOntologyMolecularFunctionhistone H3K4 trimethyltransferase activity

KMT2D SETD1B

5.35e-0410702GO:0140999
GeneOntologyMolecularFunctionprotein phosphatase inhibitor activity

BOD1 PHACTR4 CABIN1

7.19e-0450703GO:0004864
GeneOntologyMolecularFunctionprotein phosphatase binding

CDKN1B BOD1 PHACTR4 CABIN1 PTK2

8.53e-04210705GO:0019903
GeneOntologyMolecularFunctionphosphatase inhibitor activity

BOD1 PHACTR4 CABIN1

9.00e-0454703GO:0019212
GeneOntologyMolecularFunctionprofilin binding

PCLO HTT

9.22e-0413702GO:0005522
GeneOntologyCellularComponentSet1C/COMPASS complex

BOD1 SETD1B HCFC1

2.04e-0516713GO:0048188
GeneOntologyCellularComponenttight junction

OCEL1 TJP1 SIPA1L3 CCDC85C CLDN23

1.11e-04139715GO:0070160
GeneOntologyCellularComponenthistone methyltransferase complex

BOD1 KMT2D SETD1B HCFC1

1.24e-0475714GO:0035097
GeneOntologyCellularComponentsuper elongation complex

AFF2 AFF1

1.69e-046712GO:0032783
GeneOntologyCellularComponentcontractile actin filament bundle

GAS2L2 SIPA1L3 BAG3 PTK2

4.84e-04107714GO:0097517
GeneOntologyCellularComponentstress fiber

GAS2L2 SIPA1L3 BAG3 PTK2

4.84e-04107714GO:0001725
GeneOntologyCellularComponentmethyltransferase complex

BOD1 KMT2D SETD1B HCFC1

5.02e-04108714GO:0034708
GeneOntologyCellularComponentactomyosin

GAS2L2 SIPA1L3 BAG3 PTK2

6.78e-04117714GO:0042641
GeneOntologyCellularComponentactin filament bundle

GAS2L2 SIPA1L3 BAG3 PTK2

7.00e-04118714GO:0032432
GeneOntologyCellularComponentcell-cell junction

OCEL1 TJP1 SIPA1L3 CCDC85C PANX2 CLDN23 PTK2 ADD1

8.65e-04591718GO:0005911
GeneOntologyCellularComponentnuclear body

TCF7L2 SETD1B AFF2 ATF7IP GRK5 YLPM1 CBX4 PTK2 ADD1 FOXC2

9.10e-049037110GO:0016604
GeneOntologyCellularComponentbicellular tight junction

OCEL1 TJP1 CCDC85C CLDN23

1.03e-03131714GO:0005923
GeneOntologyCellularComponentcytoplasmic region

RPGRIP1 LCA5 SPAST PCLO PRKAR2A HTT

1.40e-03360716GO:0099568
GeneOntologyCellularComponentanchoring junction

OCEL1 TJP1 SIPA1L3 CCDC85C PRKAR2A SRCIN1 PANX2 CLDN23 PTK2 ADD1

1.63e-039767110GO:0070161
GeneOntologyCellularComponentapical junction complex

OCEL1 TJP1 CCDC85C CLDN23

2.06e-03158714GO:0043296
GeneOntologyCellularComponentactin cytoskeleton

GAS2L2 TJP1 SIPA1L3 BAG3 SRCIN1 PTK2 ADD1

3.37e-03576717GO:0015629
GeneOntologyCellularComponentinclusion body

BAG3 CABIN1 HTT

3.57e-0390713GO:0016234
DomainTF_AF4/FMR2

AFF2 AFF1

7.80e-054682IPR007797
DomainAF-4

AFF2 AFF1

7.80e-054682PF05110
DomainPDZ

MAST4 TJP1 GORASP1 PCLO SIPA1L3

2.24e-04151685PS50106
DomainPDZ

MAST4 TJP1 GORASP1 PCLO SIPA1L3

2.31e-04152685IPR001478
DomainMIT

SPAST CAPN7

5.77e-0410682SM00745
DomainMIT

SPAST CAPN7

5.77e-0410682PF04212
DomainHairy_orange

HES7 HES5

8.42e-0412682PF07527
DomainOrange_dom

HES7 HES5

8.42e-0412682IPR003650
DomainORANGE

HES7 HES5

9.93e-0413682PS51054
DomainMIT

SPAST CAPN7

1.16e-0314682IPR007330
DomainPost-SET_dom

KMT2D SETD1B

1.52e-0316682IPR003616
DomainPostSET

KMT2D SETD1B

1.52e-0316682SM00508
DomainPOST_SET

KMT2D SETD1B

1.52e-0316682PS50868
Domain-

MAST4 TJP1 GORASP1 SIPA1L3

2.18e-031506842.30.42.10
PathwayREACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES

BOD1 KMT2D SETD1B HCFC1

1.54e-0542514M48018
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

KMT2D GTF3C1 TJP1 PHACTR4 NFKBIE BAG3 YLPM1 CCDC85C RPRD2 HCFC1 ADD1 PRRC2B HTT

8.27e-11549711338280479
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

KMT2D SETD1B ZNF48 SEMA7A ADAMTS7 BICRA CASKIN1 GRK5 SIPA1L3 HELZ2 CABIN1 HCFC1 ADCY7 CLDN23 PRRC2B HTT

6.01e-101105711635748872
Pubmed

Structural basis for activity regulation of MLL family methyltransferases.

BOD1 KMT2D SETD1B HCFC1

1.13e-072271426886794
Pubmed

Human transcription factor protein interaction networks.

IRF2BP2 KMT2D TCF7L2 GTF3C1 BICRA ATF7IP SUPT7L NFKBIE YLPM1 CCDC85C RPRD2 CABIN1 GARRE1 HCFC1 PRRC2B

1.57e-071429711535140242
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

MYPOP KMT2D TCF7L2 ZNF48 GTF3C1 SUPT7L HES7 YLPM1 RPRD2 CBX4 CDC6 CABIN1 HCFC1 STT3B

3.01e-071294711430804502
Pubmed

The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.

BOD1 TJP1 SIPA1L3 NFKBIE BAG3 CCDC85C PRKAR2A HS1BP3 CDC6 PRRC2B NUP35 STT3B

8.65e-071007711234597346
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

IRF2BP2 KMT2D SUPT7L YLPM1 RPRD2 HCFC1 PRRC2B

1.30e-0626871733640491
Pubmed

Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.

KMT2D SETD1B HCFC1

1.77e-061271327563068
Pubmed

VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells.

CDKN1B SPAST GTF3C1 PRKAR2A HS1BP3 ADD1 HTT

2.10e-0628871723383273
Pubmed

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

BORCS6 IRF2BP2 KMT2D TJP1 SIPA1L3 RPRD2

2.18e-0618471632908313
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

TJP1 SIPA1L3 PHACTR4 NFKBIE BAG3 CCDC85C SRCIN1 HCFC1 ADD1

2.25e-0656571925468996
Pubmed

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.

BOD1 KMT2D SETD1B HCFC1

3.42e-065071437974198
Pubmed

Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development.

CDKN1B HES7 HES5

3.64e-061571314672936
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

CDKN1B IRF2BP2 KMT2D GTF3C1 PHACTR4 BAG3 YLPM1 HELZ2 AFF1 ADD1

3.82e-06774711015302935
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

PRR36 TJP1 ATF7IP CASKIN1 SIPA1L3 YLPM1 PRKAR2A CABIN1 PTK2 ADD1 PRRC2B

3.89e-06963711128671696
Pubmed

Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27.

CDKN1B BAG3

4.11e-06271216391524
Pubmed

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.

MEF2B KMT2D

4.11e-06271221796119
Pubmed

GLTSCR1 coordinates alternative splicing and transcription elongation of ZO1 to regulate colorectal cancer progression.

TJP1 BICRA

4.11e-06271235218185
Pubmed

Cloning and mapping of the alpha-adducin gene close to D4S95 and assessment of its relationship to Huntington disease.

ADD1 HTT

4.11e-0627121284592
Pubmed

Unraveling the Role of Huntingtin in Breast Cancer Metastasis.

TJP1 HTT

4.11e-06271226293574
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

LCA5 MAST4 TJP1 CAPN7 SIPA1L3 PHACTR4 NFKBIE CCDC85C GARRE1 PRRC2B

8.93e-06853711028718761
Pubmed

Lack of genetic susceptibility in takotsubo cardiomyopathy: a case-control study.

GRK5 BAG3

1.23e-05371229514624
Pubmed

p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain.

CDKN1B PTK2

1.23e-05371215557280
Pubmed

HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy.

BAG3 HTT

1.23e-05371218006506
Pubmed

PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment.

BAG3 PTK2

1.23e-05371228103122
Pubmed

[AF4/FMR2 and IL-10 gene single nucleotide polymorphisms are correlated with disease susceptibility and immune infiltration in ankylosing spondylitis].

AFF2 AFF1

1.23e-05371237313815
Pubmed

Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations.

ATF7IP HTT

1.23e-05371230452683
Pubmed

FAK is required for Schwann cell spreading on immature basal lamina to coordinate the radial sorting of peripheral axons with myelination.

CDKN1B PTK2

1.23e-05371225274820
Pubmed

BAG3 regulates formation of the SNARE complex and insulin secretion.

BAG3 PTK2

1.23e-05371225766323
Pubmed

Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2.

MEF2B CABIN1

1.23e-05371212700764
Pubmed

Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.

IRF2BP2 BICRA BAG3 YLPM1 PRKAR2A RPRD2 HCFC1

1.76e-0539971735987950
Pubmed

Dll1 and Dll4 function sequentially in the retina and pV2 domain of the spinal cord to regulate neurogenesis and create cell diversity.

CDKN1B TJP1 HES5

1.82e-052571319389377
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

IRF2BP2 TJP1 ATF7IP BAG3 YLPM1 CCDC85C RPRD2 HCFC1 ADD1 PRRC2B

1.95e-05934711033916271
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

CDKN1B GTF3C1 TJP1 GORASP1 SIPA1L3 YLPM1 CCDC85C PRKAR2A CDC6 HCFC1 PRRC2B

2.13e-051155711120360068
Pubmed

MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma.

MEF2B CABIN1

2.46e-05471223974956
Pubmed

Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms.

CDKN1B PTK2

2.46e-05471216705171
Pubmed

Cdc6 determines utilization of p21(WAF1/CIP1)-dependent damage checkpoint in S phase cells.

CDKN1B CDC6

2.46e-05471218458079
Pubmed

Mutations in SIPA1L3 cause eye defects through disruption of cell polarity and cytoskeleton organization.

TJP1 SIPA1L3

2.46e-05471226231217
Pubmed

Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice.

AFF2 AFF1

2.46e-05471211923441
Pubmed

Mediation of Af4 protein function in the cerebellum by Siah proteins.

AFF2 AFF1

2.46e-05471215459319
Pubmed

Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2.

MEF2B CABIN1

2.46e-05471210531067
Pubmed

Functional proteomics mapping of a human signaling pathway.

KMT2D MAST4 CPXM2 ATF7IP GORASP1 YLPM1 AFF1 CBX4

2.76e-0559171815231748
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

TCF7L2 AFF2 BICRA YLPM1 AFF1 PTK2 SOS2

2.83e-0543071735044719
Pubmed

Identification and characterization of a novel human PP1 phosphatase complex.

KMT2D SETD1B HCFC1

3.52e-053171320516061
Pubmed

c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.

GRK5 PTK2

4.09e-05571227232975
Pubmed

The GIT family of proteins forms multimers and associates with the presynaptic cytomatrix protein Piccolo.

PCLO PTK2

4.09e-05571212473661
Pubmed

Calpain induces N-terminal truncation of β-catenin in normal murine liver development: diagnostic implications in hepatoblastomas.

TCF7L2 PTK2

4.09e-05571222613727
Pubmed

p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity.

SRCIN1 PTK2

4.09e-05571217525734
Pubmed

Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population.

TCF7L2 FOXC2

4.09e-05571220540670
Pubmed

Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy.

RPGRIP1 LCA5

4.09e-05571225018096
Pubmed

Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus.

CAPN7 HTT

4.09e-05571214981075
Pubmed

BAG3 promotes proliferation of ovarian cancer cells via post-transcriptional regulation of Skp2 expression.

CDKN1B BAG3

4.09e-05571228624440
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

TCF7L2 GTF3C1 TJP1 BICRA SIPA1L3 CCDC85C AFF1 RPRD2 SRCIN1 PTK2 HTT SOS2

4.47e-051489711228611215
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

SETD1B SEMA7A CASKIN1 GRK5 PTK2 PRRC2B HTT

5.31e-0547571731040226
Pubmed

ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease.

CASKIN1 PCLO PRKAR2A SRCIN1 HTT

6.00e-0520271533601422
Pubmed

A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus.

TCF7L2 FOXC2

6.13e-05671217342473
Pubmed

Non-cell autonomous and non-catalytic activities of ATX in the developing brain.

TJP1 PTK2

6.13e-05671225788872
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

SPAST MAST4 TJP1 SIPA1L3 PHACTR4 BAG3 CCDC85C CBX4 GARRE1

6.32e-0586171936931259
Pubmed

The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.

KMT2D SUPT7L AFF1 NUP35

6.77e-0510671431024071
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

CASKIN1 PCLO SRCIN1 PTK2 ADD1 HTT

7.84e-0534771617114649
Pubmed

Lfng and Dll3 cooperate to modulate protein interactions in cis and coordinate oscillatory Notch pathway activation in the segmentation clock.

HES7 HES5

8.57e-05771235429490
Pubmed

A genome-wide survey on basic helix-loop-helix transcription factors in rat and mouse.

HES7 HES5

8.57e-05771219306043
Pubmed

Mouse models for the Wolf-Hirschhorn deletion syndrome.

ADD1 HTT

8.57e-05771211152656
Pubmed

Notch-Hes1 pathway contributes to the cochlear prosensory formation potentially through the transcriptional down-regulation of p27Kip1.

CDKN1B HES5

8.57e-05771219598246
Pubmed

The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.

PCLO SIPA1L3 SRCIN1 PRRC2B NUP35

8.60e-0521871533378226
Pubmed

Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.

BOD1 KMT2D SETD1B HCFC1

1.06e-0411971423508102
Pubmed

Comprehensive identification of phosphorylation sites in postsynaptic density preparations.

CASKIN1 PCLO SRCIN1 ADD1 PRRC2B

1.13e-0423171516452087
Pubmed

Host cell factors stimulate HIV-1 transcription by antagonizing substrate-binding function of Siah1 ubiquitin ligase to stabilize transcription elongation factor ELL2.

AFF1 HCFC1

1.14e-04871232479599
Pubmed

Huntingtin facilitates polycomb repressive complex 2.

CBX4 HTT

1.14e-04871219933700
Pubmed

Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.

KMT2D SETD1B

1.14e-04871223130995
Pubmed

The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.

KMT2D SETD1B

1.14e-04871222266653
Pubmed

The oscillation of Notch activation, but not its boundary, is required for somite border formation and rostral-caudal patterning within a somite.

HES7 HES5

1.14e-04871220335362
Pubmed

The murine homologues of the Huntington disease gene (Hdh) and the alpha-adducin gene (Add1) map to mouse chromosome 5 within a region of conserved synteny with human chromosome 4p16.3.

ADD1 HTT

1.14e-0487127959767
Pubmed

JAM-C Is Important for Lens Epithelial Cell Proliferation and Lens Fiber Maturation in Murine Lens Development.

CDKN1B TJP1

1.47e-04971238095908
Pubmed

Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.

KMT2D SETD1B

1.47e-04971222665483
Pubmed

FGF signaling patterns cell fate at the interface between tendon and bone.

HES7 HES5

1.47e-04971231320326
Pubmed

Cdc42- and IRSp53-dependent contractile filopodia tether presumptive lens and retina to coordinate epithelial invagination.

TJP1 PTK2

1.47e-04971219820184
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

RPGRIP1 MYPOP GTF3C1 TJP1 PCLO GRK5 SIPA1L3 YLPM1 PRRC2B NUP35 STT3B

1.56e-041442711135575683
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

TJP1 PHACTR4 BAG3 PRKAR2A HCFC1 NUP35 STT3B

1.61e-0456871737774976
Pubmed

BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.

IRF2BP2 SUPT7L RPRD2 HCFC1

1.68e-0413471425452129
Pubmed

Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells.

TJP1 BAG3 HCFC1 PTK2

1.82e-0413771437039823
Pubmed

Hesr1 and Hesr2 may act as early effectors of Notch signaling in the developing cochlea.

CDKN1B HES5

1.83e-041071218291358
Pubmed

Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A Histone H3-Lys4 methyltransferase complex to transcription start sites of transcribed human genes.

SETD1B HCFC1

1.83e-041071217998332
Pubmed

Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS.

SETD1B HCFC1

1.83e-041071218838538
Pubmed

Expression of Leukaemia associated transcription factor Af9/Mllt3 in the cerebral cortex of the mouse.

AFF2 AFF1

1.83e-041071219000783
Pubmed

Transcription factor Hes1 modulates osteoarthritis development in cooperation with calcium/calmodulin-dependent protein kinase 2.

HES7 HES5

1.83e-041071225733872
Pubmed

Ccdc85c encoding a protein at apical junctions of radial glia is disrupted in hemorrhagic hydrocephalus (hhy) mice.

TJP1 CCDC85C

1.83e-041071222056358
Pubmed

Protein phosphatase 1γ isoforms linked interactions in the brain.

PHACTR4 YLPM1 RPRD2

2.20e-045771323080069
Pubmed

Hey2 functions in parallel with Hes1 and Hes5 for mammalian auditory sensory organ development.

CDKN1B HES5

2.23e-041171218302773
Pubmed

Analysis of Ripply1/2-deficient mouse embryos reveals a mechanism underlying the rostro-caudal patterning within a somite.

HES7 HES5

2.23e-041171220346937
Pubmed

Tcf7L2 is essential for neurogenesis in the developing mouse neocortex.

TCF7L2 TJP1

2.23e-041171229751817
Pubmed

Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.

HES7 HES5

2.23e-041171217611704
Pubmed

Proliferation inhibition of astrocytes, neurons, and non-glial cells by intracellularly expressed human immunodeficiency virus type 1 (HIV-1) Tat protein.

CDKN1B CDC6

2.23e-041171215050687
Pubmed

Endothelial cell specification in the somite is compromised in Pax3-positive progenitors of Foxc1/2 conditional mutants, with loss of forelimb myogenesis.

TJP1 FOXC2

2.23e-041171226839363
Pubmed

Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation.

CDKN1B FOXC2

2.68e-041271215342473
Pubmed

Notch inhibition induces mitotically generated hair cells in mammalian cochleae via activating the Wnt pathway.

CDKN1B HES5

2.68e-041271225535395
Pubmed

Dll3 is expressed in developing hair cells in the mammalian cochlea.

CDKN1B HES5

2.68e-041271217823936
Pubmed

The period of the somite segmentation clock is sensitive to Notch activity.

HES7 HES5

2.68e-041271221795391
Pubmed

Expression of Notch signaling pathway genes in mouse embryos lacking beta4galactosyltransferase-1.

HES7 HES5

2.68e-041271216412699
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

BICRA CBX4 GARRE1 PRRC2B

2.71e-0415271438360978
InteractionWWTR1 interactions

KMT2D GTF3C1 TJP1 PHACTR4 NFKBIE BAG3 CCDC85C RPRD2 HCFC1 PRRC2B NUP35 HTT

2.16e-084227012int:WWTR1
InteractionENTR1 interactions

BORCS6 RPGRIP1 LCA5 TJP1 SIPA1L3 CCDC85C GARRE1

4.01e-06188707int:ENTR1
InteractionHNF1B interactions

KMT2D TCF7L2 BICRA ATF7IP CABIN1 PRRC2B NUP35

4.30e-06190707int:HNF1B
InteractionWDR82 interactions

BOD1 KMT2D SETD1B GRK5 CBX4 HCFC1 HTT

9.10e-06213707int:WDR82
InteractionTOP3B interactions

KMT2D SETD1B ZNF48 SEMA7A ADAMTS7 BICRA CASKIN1 GRK5 SIPA1L3 HELZ2 CABIN1 HCFC1 ADCY7 CLDN23 PRRC2B HTT

3.39e-0514707016int:TOP3B
InteractionPAX6 interactions

IRF2BP2 KMT2D TCF7L2 GTF3C1 GAS2L2 BICRA CABIN1 PRRC2B

3.88e-05366708int:PAX6
InteractionVASP interactions

IRF2BP2 TJP1 SIPA1L3 PHACTR4 BAG3 CCDC85C HS1BP3

7.15e-05294707int:VASP
InteractionYWHAG interactions

CDKN1B LCA5 SPAST MAST4 TJP1 GRK5 SIPA1L3 PHACTR4 BAG3 CCDC85C CBX4 GARRE1 PTK2 HTT

8.34e-0512487014int:YWHAG
InteractionSP7 interactions

IRF2BP2 KMT2D TCF7L2 BICRA YLPM1 RPRD2 PRRC2B

8.82e-05304707int:SP7
InteractionPCLO interactions

SPAST PCLO CBX4 HTT

1.03e-0470704int:PCLO
InteractionAMPH interactions

SPAST CABIN1 PTK2 HTT

1.15e-0472704int:AMPH
InteractionSMG7 interactions

IRF2BP2 KMT2D YLPM1 RPRD2 GARRE1 PRRC2B NUP35

1.19e-04319707int:SMG7
InteractionSIAH1 interactions

CDKN1B AFF2 BAG3 AFF1 HCFC1 HTT

1.25e-04223706int:SIAH1
InteractionCNOT7 interactions

BAG3 GARRE1 PRRC2B HTT FOXC2

1.27e-04140705int:CNOT7
InteractionSETD1B interactions

BOD1 KMT2D SETD1B HCFC1

1.35e-0475704int:SETD1B
InteractionPPP1CA interactions

IRF2BP2 PHACTR4 YLPM1 CCDC85C PRKAR2A RPRD2 WDFY4 HCFC1 PTK2 HTT

1.38e-046967010int:PPP1CA
InteractionUBN1 interactions

TCF7L2 GTF3C1 TJP1 CABIN1

1.49e-0477704int:UBN1
InteractionNCOA6 interactions

KMT2D SETD1B HCFC1 NUP35 HTT

1.50e-04145705int:NCOA6
InteractionHEYL interactions

RPGRIP1 ATF7IP HTT

1.68e-0431703int:HEYL
InteractionYWHAB interactions

CDKN1B LCA5 MAST4 TJP1 GRK5 SIPA1L3 PHACTR4 BAG3 CCDC85C CBX4 GARRE1 HTT

1.76e-0410147012int:YWHAB
InteractionCLTA interactions

TCF7L2 SPAST MAST4 SIPA1L3 BAG3 WDFY4 HTT

2.14e-04351707int:CLTA
InteractionASF1A interactions

IRF2BP2 KMT2D GTF3C1 BICRA CABIN1 HCFC1

2.27e-04249706int:ASF1A
InteractionMEF2D interactions

MEF2B KMT2D CABIN1 NUP35

2.39e-0487704int:MEF2D
InteractionCRYBA4 interactions

TCF7L2 GTF3C1 TJP1

2.43e-0435703int:CRYBA4
Cytoband22q13.33

LMF2 PANX2

1.60e-033871222q13.33
GeneFamilyAF4/FMR2 family|Super elongation complex

AFF2 AFF1

3.62e-0544521145
GeneFamilyPDZ domain containing

MAST4 TJP1 GORASP1 PCLO SIPA1L3

3.66e-051524551220
GeneFamilyAF4/FMR2 family|Super elongation complex

AFF2 AFF1

2.16e-0494521280
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

PHACTR4 YLPM1 HCFC1 PTK2

1.05e-03181454694
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

KMT2D SETD1B

3.23e-0334452487
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

RPGRIP1 PCLO

3.62e-0336452823
CoexpressionGSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP

ATF7IP HELZ2 RPRD2 CBX4 HECA ADD1 PRRC2B

1.19e-06200717M7195
CoexpressionGSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN

KMT2D GORASP1 GRK5 RPRD2 ADCY7 ADD1

1.69e-05199716M7711
CoexpressionGSE40273_XBP1_KO_VS_WT_TREG_DN

SEMA7A GRK5 HELZ2 PRKAR2A WDFY4 STT3B

1.69e-05199716M9124
CoexpressionGSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN

BORCS6 SPAST SETD1B ATF7IP CDC6 HCFC1

1.74e-05200716M7796
CoexpressionTHAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN

SETD1B BICRA PHACTR4 CACNA1I CBX4 C1orf162 GARRE1 HCFC1 ADCY7

5.24e-05634719M40866
CoexpressionGSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN

KMT2D SEMA7A SUPT7L AFF1 RPRD2

6.85e-05157715M7733
CoexpressionBUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP

TCF7L2 TJP1 ATF7IP BAG3 HS1BP3 GARRE1 HECA ADCY7 PRRC2B SOS2

7.13e-058227110M6782
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAST4 AFF2 CAPN7 PCLO YLPM1 AFF1

3.57e-07174716f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAST4 ENHO AFF2 CAPN7 PCLO AFF1

4.08e-07178716fcbbcc44271515de1969b4732b6441c012693d5f
ToppCellCOVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type

MAST4 TJP1 BAG3 HES5 GARRE1

1.26e-05188715eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCellCOVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

TJP1 GRK5 BAG3 HES5 GARRE1

1.32e-0519071507b675befcd1d0a9c90cb17b5d22323468325d51
DrugMedrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A

TCF7L2 AFF2 PCLO CCDC85C CABIN1 HCFC1 PTK2

2.23e-061947074727_DN
DrugTerbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A

TCF7L2 SPAST MAST4 SIPA1L3 SUPT7L PTK2 ADD1

2.47e-061977076240_DN
DrugBudesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A

MAST4 SIPA1L3 NFKBIE YLPM1 PRKAR2A ADCY7 SOS2

2.55e-061987075431_DN
DrugNSC 97945

PTK2 ADD1 STT3B

1.51e-0516703CID000097054
DrugEthacrynic acid [58-54-8]; Up 200; 13.2uM; HL60; HG-U133A

LMF2 PCLO GARRE1 ADCY7 ADD1 HTT

2.40e-051877061565_UP
DrugLithocholic acid [434-13-9]; Up 200; 10.6uM; HL60; HT_HG-U133A

BORCS6 LMF2 PCLO YLPM1 GARRE1 HCFC1

2.40e-051877062571_UP
DrugLovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A

LMF2 PRR36 PCLO CCDC85C CABIN1 ADD1

2.87e-051937064978_UP
DrugOmeprazole [73590-58-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A

CDK20 MAST4 SUPT7L PRKAR2A CBX4 SOS2

2.87e-051937062828_DN
DrugButylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A

TCF7L2 LMF2 SIPA1L3 CACNA1I CABIN1 SOS2

2.87e-051937065608_DN
DrugIohexol [66108-95-0]; Up 200; 4.8uM; PC3; HT_HG-U133A

SEMA7A GRK5 HS1BP3 HCFC1 PTK2 PRRC2B

2.95e-051947064643_UP
DrugMephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A

CDK20 MAST4 SUPT7L PRKAR2A CABIN1 SOS2

3.04e-051957063580_DN
DrugHydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A

CDK20 TCF7L2 MAST4 PRR36 SIPA1L3 PTK2

3.04e-051957061687_DN
DrugIproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A

TCF7L2 MAST4 HS1BP3 CABIN1 ADD1 HTT

3.04e-051957062125_DN
DrugCorticosterone [50-22-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A

AFF2 SEMA7A GRK5 CCDC85C PRKAR2A HCFC1

3.04e-051957064145_DN
DrugGemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A

MAST4 PRR36 SIPA1L3 PRKAR2A AFF1 SOS2

3.13e-051967065488_UP
DrugIndapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A

TCF7L2 LMF2 PRR36 SIPA1L3 PRKAR2A SOS2

3.13e-051967063970_DN
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

CDK20 MAST4 PRR36 PRKAR2A CABIN1 SOS2

3.13e-051967065604_DN
DrugClofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A

BORCS6 AFF2 ADAMTS7 AFF1 CACNA1I SOS2

3.13e-051967065642_DN
DrugDeferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A

LMF2 MAST4 PRR36 SIPA1L3 HCFC1 SOS2

3.13e-051967063936_DN
DrugHydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A

TCF7L2 LMF2 MAST4 YLPM1 CBX4 CABIN1

3.13e-051967061487_DN
DrugSotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A

BORCS6 LMF2 SEMA7A PRR36 CCDC85C PRRC2B

3.22e-051977064160_DN
DrugSulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A

TCF7L2 SETD1B PRR36 BICRA SUPT7L CCDC85C

3.22e-051977061810_DN
DrugStreptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A

TCF7L2 LMF2 AFF2 YLPM1 CABIN1 HCFC1

3.22e-051977067194_DN
DrugBenfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A

LMF2 MAST4 PRR36 GRK5 SIPA1L3 CBX4

3.22e-051977063931_DN
DrugAdiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A

ZNF142 TCF7L2 LMF2 YLPM1 HCFC1 SOS2

3.22e-051977067037_DN
DrugAlprostadil [745-65-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A

CCDC85C AFF1 CABIN1 HCFC1 ADCY7 SOS2

3.22e-051977067358_DN
DrugPentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A

LMF2 SIPA1L3 YLPM1 CBX4 CABIN1 SOS2

3.31e-051987067375_UP
DrugHydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A

BORCS6 TCF7L2 SIPA1L3 CCDC85C GARRE1 SOS2

3.31e-051987063292_DN
DrugRibostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A

LMF2 SETD1B MAST4 PRR36 HCFC1 SOS2

3.31e-051987066765_UP
DrugCinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A

TCF7L2 BICRA NFKBIE RPRD2 CABIN1 PRRC2B

3.31e-051987067174_DN
DrugLiothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A

BORCS6 LMF2 AFF2 CCDC85C CACNA1I SOS2

3.31e-051987064947_UP
Drug(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; PC3; HT_HG-U133A

LMF2 MAST4 GTF3C1 GRK5 PRKAR2A CABIN1

3.31e-051987066343_DN
DrugCorynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A

CDK20 ZNF142 SPAST MAST4 ADCY7 SOS2

3.31e-051987062786_DN
DrugNitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A

LMF2 MAST4 CCDC85C PRKAR2A GARRE1 ADCY7

3.31e-051987066043_DN
DrugCyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

MAST4 GRK5 SIPA1L3 CCDC85C HCFC1 SOS2

3.31e-051987063882_DN
DrugSulfanilamide [63-74-1]; Up 200; 23.2uM; MCF7; HT_HG-U133A

TCF7L2 LMF2 PRR36 CACNA1I ADCY7 SOS2

3.40e-051997063449_UP
DrugNalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A

TCF7L2 PRR36 SIPA1L3 CABIN1 HCFC1 SOS2

3.40e-051997064691_DN
DrugMeptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A

TCF7L2 SEMA7A PCLO CACNA1I CABIN1 SOS2

3.40e-051997064774_UP
DrugPralidoxime chloride [51-15-0]; Up 200; 23.2uM; PC3; HT_HG-U133A

CDK20 SEMA7A GRK5 HCFC1 ADD1 SOS2

3.50e-052007066283_UP
Drugestradiol, USP; Down 200; 0.01uM; PC3; HG-U133A

ZNF142 SETD1B MAST4 AFF1 CDC6 HTT

3.50e-05200706665_DN
DrugTinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A

LMF2 MAST4 SEMA7A PRR36 SIPA1L3 CCDC85C

3.50e-052007063896_DN
Drug7B-forskolin

SUPT7L PRKAR2A ADCY7

6.88e-0526703CID000130638
DrugStrophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A

TCF7L2 ATF7IP NFKBIE CBX4 HCFC1

1.99e-041747051302_UP
DrugPhenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A

TCF7L2 MAST4 GRK5 YLPM1 PTK2

2.16e-041777054652_DN
DrugCalpain inhibitor I

CDKN1B GORASP1 CAPN7 SUPT7L NFKBIE PTK2

2.22e-04280706CID000004332
DrugPhenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

TCF7L2 MAST4 YLPM1 CCDC85C SOS2

2.52e-041837055613_DN
DrugZuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

CDK20 BORCS6 LMF2 CAPN7 GRK5

2.52e-041837054843_UP
DrugLycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A

MAST4 CBX4 CABIN1 HCFC1 ADCY7

2.71e-041867056051_DN
DrugLY 294002; Up 200; 10uM; MCF7; HT_HG-U133A

LMF2 PCLO SIPA1L3 HECA SOS2

2.78e-041877055233_UP
DrugPhenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

TCF7L2 SPAST GRK5 SIPA1L3 PRKAR2A

2.92e-041897055248_DN
Drugwortmannin; Down 200; 1uM; MCF7; HT_HG-U133A_EA

TCF7L2 SUPT7L CCDC85C CDC6 SOS2

2.92e-04189705869_DN
DrugAcacetin [480-44-4]; Down 200; 14uM; HL60; HT_HG-U133A

OCEL1 PRKAR2A AFF1 HTT SOS2

2.99e-041907052189_DN
Drug17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A

LMF2 SIPA1L3 BAG3 YLPM1 ADCY7

3.07e-041917056933_UP
DrugMesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A

TCF7L2 BICRA CAPN7 HTT SOS2

3.14e-041927056162_DN
DrugRapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A

LMF2 SETD1B MAST4 SIPA1L3 YLPM1

3.14e-041927056958_UP
Drug2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A

BORCS6 PRR36 GRK5 CCDC85C HECA

3.14e-041927055206_UP
DrugHydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A

SEMA7A ADAMTS7 GRK5 CACNA1I SOS2

3.22e-041937052283_UP
DrugMebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A

LMF2 MAST4 SIPA1L3 CCDC85C CABIN1

3.22e-041937057147_UP
DrugThiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A

CDK20 TCF7L2 MAST4 GRK5 SIPA1L3

3.22e-041937052894_DN
DrugAcetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A

TCF7L2 PRR36 SUPT7L CCDC85C SOS2

3.30e-041947055384_DN
DrugNorcyclobenzaprine [303-50-4]; Down 200; 15.4uM; HL60; HT_HG-U133A

BORCS6 TCF7L2 LMF2 PRKAR2A SOS2

3.30e-041947052469_DN
DrugNeomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A

TCF7L2 LMF2 MAST4 CABIN1 HCFC1

3.30e-041947057221_DN
DrugAltretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A

SIPA1L3 CABIN1 HCFC1 PRRC2B SOS2

3.30e-041947056467_DN
DrugCyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A

LMF2 PCLO CCDC85C HCFC1 SOS2

3.30e-041947054411_DN
Drugtroglitazone; Up 200; 10uM; MCF7; HT_HG-U133A

CDK20 SPAST SEMA7A PRKAR2A SOS2

3.30e-041947055229_UP
DrugPentamidine isethionate [140-64-7]; Up 200; 6.8uM; PC3; HT_HG-U133A

CDK20 PRR36 CCDC85C AFF1 HCFC1

3.30e-041947054573_UP
DrugDanazol [17230-88-5]; Down 200; 11.8uM; PC3; HG-U133A

SETD1B RPRD2 ADD1 PRRC2B HTT

3.30e-041947051954_DN
DrugICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A

TCF7L2 BICRA CABIN1 GARRE1 HCFC1

3.30e-041947051179_DN
DrugZomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A

CDK20 SIPA1L3 CCDC85C HS1BP3 SOS2

3.30e-041947053454_DN
DrugSertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A

LMF2 SPAST MAST4 GRK5 SIPA1L3

3.30e-041947056811_DN
DrugCyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

CDK20 TCF7L2 CCDC85C ADCY7 SOS2

3.37e-041957054358_DN
Drugradicicol; Up 200; 0.1uM; PC3; HG-U133A

GRK5 BAG3 AFF1 ADCY7 HTT

3.37e-04195705449_UP
Drug5140203; Down 200; 15uM; MCF7; HT_HG-U133A_EA

CDK20 LMF2 PRR36 YLPM1 CABIN1

3.37e-04195705908_DN
Drug5213008; Down 200; 18uM; MCF7; HT_HG-U133A_EA

TCF7L2 LMF2 PRR36 PHACTR4 CABIN1

3.37e-04195705898_DN
DrugProgesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A

BORCS6 TJP1 PCLO CACNA1I SOS2

3.37e-041957052426_UP
DrugSecurinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A

CDK20 MAST4 YLPM1 CCDC85C HS1BP3

3.37e-041957053470_DN
DrugEthionamide [536-33-4]; Down 200; 24uM; MCF7; HT_HG-U133A

CDK20 SEMA7A PCLO CCDC85C SOS2

3.37e-041957054418_DN
DrugCholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A

SEMA7A GRK5 PHACTR4 CACNA1I SOS2

3.37e-041957053298_UP
DrugNabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A

TCF7L2 MAST4 PRR36 NFKBIE SOS2

3.37e-041957055428_DN
DrugTiclopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A

LMF2 PRR36 SIPA1L3 CCDC85C SOS2

3.37e-041957054155_DN
DrugBicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A

LMF2 AFF2 GRK5 CABIN1 HCFC1

3.37e-041957052796_UP
DrugFenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A

SETD1B SUPT7L PRKAR2A HS1BP3 SOS2

3.37e-041957053714_DN
DrugTacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A

SETD1B SUPT7L CBX4 CABIN1 PRRC2B

3.37e-041957055297_UP
DrugEthacrynic acid [58-54-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A

LMF2 ADAMTS7 PCLO AFF1 SOS2

3.37e-041957053181_UP
DrugNaphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HG-U133A

MAST4 GTF3C1 SIPA1L3 CDC6 HCFC1

3.37e-041957051886_DN
DrugProbucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A

PRR36 SIPA1L3 PRKAR2A GARRE1 SOS2

3.37e-041957055626_DN
DrugAC1L1IZ2

GTF3C1 PRKAR2A PANX2 ADCY7 PTK2 STT3B

3.45e-04304706CID000004795
DrugNiridazole [61-57-4]; Down 200; 18.6uM; HL60; HT_HG-U133A

TCF7L2 PRKAR2A CABIN1 HTT SOS2

3.45e-041967052440_DN
DrugPhenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A

CDK20 BICRA SIPA1L3 ADCY7 SOS2

3.45e-041967053217_DN
DrugDobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; PC3; HT_HG-U133A

GRK5 SIPA1L3 CCDC85C HS1BP3 CABIN1

3.45e-041967056286_DN
DrugPirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A

TCF7L2 BICRA SUPT7L HCFC1 PRRC2B

3.45e-041967057226_DN
Drugradicicol; Up 200; 0.1uM; SKMEL5; HG-U133A

GTF3C1 BICRA BAG3 CCDC85C AFF1

3.45e-04196705493_UP
DrugVancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A

LMF2 CCDC85C PRKAR2A HCFC1 ADCY7

3.45e-041967054423_DN
DrugAcetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A

BORCS6 ADAMTS7 CCDC85C AFF1 SOS2

3.45e-041967051686_UP
DrugHydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A

LMF2 SPAST PHACTR4 CABIN1 PRRC2B

3.45e-041967052119_DN
DrugHecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A

TCF7L2 SPAST MAST4 YLPM1 HCFC1

3.45e-041967057175_DN
DrugSuramin sodium salt; Down 200; 10uM; MCF7; HT_HG-U133A

CDK20 TCF7L2 NFKBIE GARRE1 SOS2

3.45e-041967057496_DN
DrugImipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A

MAST4 PRR36 PHACTR4 CABIN1 PTK2

3.45e-041967051685_DN
DrugSulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A

SETD1B SEMA7A GRK5 AFF1 HCFC1

3.45e-041967054724_UP
DrugAminophylline [317-34-0]; Down 200; 9.6uM; PC3; HT_HG-U133A

LMF2 GRK5 CCDC85C CABIN1 PRRC2B

3.45e-041967056295_DN
Diseasehousehold income

TCF7L2 MAST4 ATF7IP CACNA1I ADD1 HTT

7.91e-05304696EFO_0009695
Diseasecortical thickness

LMAN1L IRF2BP2 TCF7L2 MAST4 ADAMTS7 YLPM1 PRKAR2A AFF1 FOXC2 SOS2

2.52e-0411136910EFO_0004840
DiseaseAntihypertensive use measurement

LMAN1L TCF7L2 ENHO PHACTR4 BAG3

3.96e-04265695EFO_0009927
Diseaselung small cell carcinoma (is_marker_for)

CDKN1B PTK2

6.33e-0416692DOID:5409 (is_marker_for)
DiseaseLeber congenital amaurosis

RPGRIP1 LCA5

6.33e-0416692cv:C0339527
Diseaseintellectual disability (implicated_via_orthology)

BOD1 MEF2B ATF7IP

7.33e-0475693DOID:1059 (implicated_via_orthology)
DiseaseHydrops Fetalis

FOXC2 SOS2

8.98e-0419692C0020305
Diseasehydrocephalus (implicated_via_orthology)

CCDC85C ADD1

8.98e-0419692DOID:10908 (implicated_via_orthology)
Diseasesex interaction measurement, cerebral amyloid angiopathy

SRCIN1 HS1BP3

1.10e-0321692EFO_0006790, EFO_0008343
DiseaseNystagmus

MAST4 AFF2

1.10e-0321692HP_0000639
DiseaseLeber Congenital Amaurosis

RPGRIP1 LCA5

1.21e-0322692C0339527
DiseaseSezary Syndrome

CDKN1B KMT2D

1.82e-0327692C0036920
Diseasetype 2 diabetes mellitus (implicated_via_orthology)

TCF7L2 AFF2 AFF1

1.93e-03105693DOID:9352 (implicated_via_orthology)
Diseaseunipolar depression, irritable bowel syndrome

TCF7L2 PCLO

1.96e-0328692EFO_0000555, EFO_0003761
Diseaselung small cell carcinoma (is_implicated_in)

KMT2D PTK2

1.96e-0328692DOID:5409 (is_implicated_in)
Diseaselongevity, healthspan, parental longevity

TCF7L2 HTT

2.10e-0329692EFO_0004300, EFO_0007796, EFO_0009762

Protein segments in the cluster

PeptideGeneStartEntry
HHRPDPHPPAPGKKK

nan

41

A8MWP4
PHPPAPGKKKSSPVG

nan

46

A8MWP4
PIPQRLGGPAPKAHP

CDK20

301

Q8IZL9
CPEKAPPPQKPSHEG

ENHO

56

Q6UWT2
PPRGRNKATAHKPAP

AFF2

666

P51816
PPPSQHLPRPKGDAA

ADCY7

461

P51828
PPRPPKGACKVPAQE

CDKN1B

91

P46527
GPAKPPAHRPCGAQP

ADAMTS7

1506

Q9UKP4
REKSAPEPPPPGKHS

CPXM2

91

Q8N436
PRPPCQPQPGPHKAK

OCEL1

96

Q9H607
PIGAIPKGHKPRPHP

OCEL1

131

Q9H607
KTPKNGPPPCPRLGH

HCFC1

126

P51610
KRAHGTPPPVSPKPP

CASKIN1

1261

Q8WXD9
AKPPSPGAPALHVPA

CASKIN1

1326

Q8WXD9
PGAPALHVPAKPPRA

CASKIN1

1331

Q8WXD9
RPPNKPQKGPSHDLP

HECA

226

Q9UBI9
AKAAAKAPRPPGQPP

LMAN1L

441

Q9HAT1
PCTHPPGPVKEPQEK

NFKBIE

186

O00221
PLLPPGPHKAPDGKA

CCDC85C

226

A6NKD9
HEKSQPGPAKPPAQP

PCLO

321

Q9Y6V0
HHQAPRKPSPKGLPN

LCA5

61

Q86VQ0
AHLKEPPPAASKGAP

FOXC2

181

Q99958
KQPPIPPPKPAHRNS

PHACTR4

256

Q8IZ21
RIPTQPPSYHKKPPG

GORASP1

201

Q9BQQ3
RPAAPKAGPPGLVHP

MEF2B

171

Q02080
PGPAVAEEPLHRPKK

HTT

76

P42858
PRKPAVPPKAGPAEA

HS1BP3

341

Q53T59
LSSRHKNPAPPEGKP

BORCS6

106

Q96GS4
PPEGHPGKPEPSRAK

CABIN1

2111

Q9Y6J0
VKPKPPPVRAHFPLG

CAPN7

166

Q9Y6W3
PGSFLKPPAPPVQHE

GAS2L2

281

Q8NHY3
KKAAVPAPPPEPEGQ

BOD1

161

Q96IK1
APAPAKPGPHAKEPR

CACNA1I

471

Q9P0X4
PPPPAHKAAPKGFKA

GARRE1

1041

O15063
QPHSKERAGKPPPPG

CBX4

131

O00257
NTPHLPPCSPPKQGK

CDC6

66

Q99741
KKRHEHPPNPPVSPG

ATF7IP

661

Q6VMQ6
KTNHKDGPGEARPPP

MAST4

2041

O15021
KGKDPAPAQPPPARK

MAST4

2561

O15021
HPPPEPGPDRVADAK

PRKAR2A

61

P13861
ERSPHPPQEVKDPPG

CCDC192

256

P0DO97
KGNPIHARGKVPPHP

HELZ2

761

Q9BYK8
DLNRNHPPEPPKKGL

GRK5

536

P34947
PPPHRQDGAPKAPLP

HES7

201

Q9BYE0
TPPKPGEAEAPPKHP

BAG3

406

O95817
GTVDHPPPAAPERKP

BICRA

1361

Q9NZM4
KPQAPDPHSDPPAKL

C1orf162

96

Q8NEQ5
KEAALAHAAPPPPPG

RPRD2

1246

Q5VT52
AKEKQPPPPAHRGPA

IRF2BP2

256

Q7Z5L9
DGQHRPPPAQHRKPK

CLDN23

226

Q96B33
APAPAPPPAPDKKHA

PANX2

496

Q96RD6
QPVVPAHKDKSGAPP

NUP35

76

Q8NFH5
HTAGAPVPEKPKRGP

RPGRIP1

151

Q96KN7
PPPLPPRKKFDHDAS

SOS2

1146

Q07890
KPGNLSRPPPVVVPH

LMF2

486

Q9BU23
APPKKPPRPGAPGHL

PTK2

871

Q05397
GTPRAPAHPSQPKPK

PRR36

261

Q9H6K5
AKAPRPAKPHKPPGS

SIPA1L3

1326

O60292
PKKRHEDLVPPAGSP

SETD1B

1646

Q9UPS6
AGPAPPPESPHKRNL

SPAST

36

Q9UBP0
DPPLHQPSANKPKPP

SUPT7L

36

O94864
PAAPAKEPKAPGAAP

HES5

126

Q5TA89
PRAPPEAPHPGKRSC

AFF1

571

P51825
QKEKSPPDQPAVPHP

ADD1

596

P35611
PPPPLAGDKPHKCPE

ZNF48

441

Q96MX3
PPKAPHGQKAAPRTE

SRCIN1

966

Q9C0H9
AHKAAGGAAPPKPAP

STT3B

41

Q8TCJ2
PADVDPKTGIPRPPH

TCF7L2

221

Q9NQB0
KPHPARTAAGKPLPG

WDFY4

2816

Q6ZS81
RKAPDPQPPPRKLHG

PRRC2B

446

Q5JSZ5
EPHKECPNPKPDKAP

SEMA7A

536

O75326
SHQPPPAPRVEKKPE

YLPM1

1801

P49750
LRPEAQPHPSAGPKP

TJP1

1171

Q07157
PKKHHLDPVPPAGNS

ZNF142

996

P52746
HPLKKQPPSFPGAAE

GTF3C1

526

Q12789
LHKPPRPQPPEVAFK

KMT2D

2466

O14686
GDRFVIPPHPKVPAP

KIAA1522

596

Q9P206
APLPPHDSPPHKRRK

MYPOP

371

Q86VE0